S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marinus Pharmaceuticals Inc (MRNS)
Marinus Pharmaceuticals Inc (MRNS) Financials

Marinus Pharmaceuticals Inc (MRNS)

0.3248

0.003

(0.93%)

Closed November 27 3:00PM

Delayed by 15 minutes

0.3279

0.0031

(0.95%)

After Hours: 6:48PM

Delayed by 15 minutes

Marinus Pharmaceuticals Inc Financial Summary

The current MRNS market cap is 18.1M. The company's latest EPS is USD -2.5624 and P/E is -0.12.

Income Statement

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	6.08M	7.34M	7.19M	7.68M	8.06M
Operating Income	-31.44M	-31.65M	-35.44M	-35.82M	-31.44M
Net Income	-31.93M	-32.97M	-41.77M	-38.67M	-35.83M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	1.72M	15.35M	25.48M	30.99M
Operating Income	-54.42M	-67.94M	-96.93M	-112.79M	-131.49M
Net Income	-54.12M	-67.48M	-98.78M	-19.82M	-141.41M

Balance Sheet

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	201.2M	200.81M	170.91M	137.35M	87.08M
Total Liabilities	143.86M	146.27M	154.14M	153.78M	134.43M
Total Equity	57.34M	54.54M	16.77M	-16.43M	-47.35M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	98.84M	150.46M	136.84M	259.52M	170.91M
Total Liabilities	11.07M	13.26M	83.35M	143.52M	154.14M
Total Equity	59.57M	137.2M	53.49M	116M	16.77M

Cash Flow

Annual Quarterly

Quarter End	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-65.84M	-91.01M	-118M	-37.46M	-68.3M
Investing	-46.99M	-35.07M	-28.61M	20.89M	29.85M
Financing	63k	25.97M	26.63M	257k	-17.44M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	-48.63M	-60.91M	-55.48M	-112.89M	-118M
Investing	3.88M	-738k	-1.42M	105.77M	-28.61M
Financing	67.97M	109.22M	41.31M	124.74M	26.63M

Stats and Ratios

Market Cap	18.1M
Price to Earnings Ratio	-0.12
Price to Sales Ratio	0.57
Price to Cash Ratio	0.15
Price to Book Ratio	1.05
Dividend Yield	-

Share Statistics

Shares Outstanding	55.19M
Average Volume (1 week)	850.59k
Average Volume (1 Month)	1.53M
52 Week Change	-94.87%
52 Week High	11.26
52 Week Low	0.2603
Spread (Intraday)	0.01 (3.17%)

Company Info

Company Name	Marinus Pharmaceuticals Inc
Address	3411 silverside road tatnall building wilmington, delaware 19810
Website	https://www.marinuspharma.com
Industry	pharmaceutical preparations (2834)

Marinus Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions